Subject wise

Ch 1 Osteogenesis Imperfecta 1 → Ch 2 Marfan syndrome 3 → Ch 3 Nervous system 8 → Ch 4 Septic Arthritis 1 → Ch 5 Atherosclerosis 1 → Ch 6 Carpal tunnel syndrome 1 → Ch 7 Cystic fibrosis 1 → Ch 8 Granulomatous Inflammation 1 → Ch 9 Pleomorphic adenoma 1 → Ch 10 Achalasia 1 → Ch 11 Glomerulonephritis 1 → Ch 12 Chronic liver disease 1 → Ch 13 Alveolar ventilation 2 → Ch 14 Gluconeogenesis 2 → Ch 15 Pneumothorax 2 → Ch 16 Glomerular filtration 5 → Ch 17 Telomeres and Telomerase 1 → Ch 18 Diabetes insipidus 1 → Ch 19 Tumor markers 1 → Ch 20 Basal Ganglia 1 → Ch 21 Conjunctival Epithelium 1 → Ch 22 Gallbladder Histology 2 → Ch 23 Obstetrics 6 → Ch 24 Cardiovascular Physiology & Disease 15 → Ch 25 Anatomy & Embryology 1 → Ch 26 Gynaecology & Reproductive Medicine 8 → Ch 27 Neurological Localization & Function 3 → Ch 28 Emergency 17 → Ch 29 Critical Care & Perioperative Medicine 17 → Ch 30 Hematologic Disorders & Diagnostics 1 → Ch 31 Endocrine Physiology & Disease 3 → Ch 32 Pharmacology & Adverse Drug Effects 11 → Ch 33 Microbiology & Infectious Disease 1 → Ch 34 Neonatal Medicine & Development 1 → Ch 35 Gastrointestinal System 2 → Ch 36 Respiratory System 3 → Ch 37 General Pathology & Cellular Injury 7 → Ch 38 Biochemistry & Metabolism 3 → Ch 39 Renal Physiology & Disease 8 → Ch 40 Gastrointestinal & Hepatobiliary Disease 1 → Ch 41 Genetics & Chromosomal Disorders 3 → Ch 42 General Pathology 3 → Ch 43 Hematology 2 → Ch 44 General Medical Knowledge 5 → Ch 45 Musculoskeletal System 4 → Ch 46 Cardiovascular Disorders & Emergencies 6 → Ch 47 Ophthalmology 1 → Ch 48 Immunology & Transplantation 1 → Ch 49 Innervation of the hand 6 → Ch 50 Leukocyte extravasation 3 → Ch 51 p53 and DNA damage 2 → Ch 52 Tetracycline mechanism of action 1 → Ch 53 Respiratory changes in pregnancy 1 → Ch 54 Acid–base disorders 16 → Ch 55 Obstructive and restrictive lung physiology 4 → Ch 56 Cerebrospinal fluid properties 2 → Ch 57 Body fluid compartments 4 → Ch 58 Internal capsule 4 → Ch 59 Cerebral arterial territories 1 → Ch 60 Inhalational anaesthetics 1 → Ch 61 Organophosphate poisoning 3 → Ch 62 Respiratory carcinogens and epithelial changes 8 → Ch 63 Cytomegalovirus colitis 2 → Ch 64 Polycythaemia vera 2 → Ch 65 Hepatocellular accumulation 1 → Ch 66 Heparin selection and monitoring 1 → Ch 67 Gas and fluid flow laws 2 → Ch 68 Multiple myeloma 2 → Ch 69 Spinal accessory nerve 3 → Ch 70 Somite and skeletal muscle development 1 → Ch 71 Scapular stabilisation 2 → Ch 72 Bronchial anatomy and aspiration 3 → Ch 73 Antiemetics and prokinetic drugs 5 → Ch 74 Starling forces and filtration 1 → Ch 75 Apoptosis 4 → Ch 76 Inguinal canal anatomy 2 → Ch 77 Diuretic mechanisms and adverse effects 6 → Ch 78 Opioid pharmacology 1 → Ch 79 Intravenous anaesthetics 2 → Ch 80 Helminthic infections 2 → Ch 81 Chronic myeloid leukaemia 1 → Ch 82 Vitamin K and anticonvulsants 1 → Ch 83 Contact activation of coagulation 1 → Ch 84 Bacterial meningitis 3 → Ch 85 Sickle cell disease 1 → Ch 86 Cardiac output during exercise 3 → Ch 87 Antimuscarinic bronchodilators 1 → Ch 88 Deep fibular nerve 1 → Ch 89 Postmortem clotting 1 → Ch 90 Pudendal nerve 2 → Ch 91 Leukotriene receptor antagonists 1 → Ch 92 Branched-chain amino acid metabolism 1 → Ch 93 Hydrocele 3 → Ch 94 Riboflavin deficiency 2 → Ch 95 Aphasia and language localisation 2 → Ch 96 Hyperaemia 2 → Ch 97 Knee flexion 1 → Ch 98 Neurogenic bladder 5 → Ch 99 Urea cycle and hepatic encephalopathy 1 → Ch 100 Cholesterol biosynthesis 1 → Ch 101 Botulinum toxin 3 → Ch 102 Myasthenia gravis 4 → Ch 103 Turner syndrome 6 → Ch 104 Facial nerve lesions 1 → Ch 105 Aspirin pharmacology 3 → Ch 106 Coronary arterial territories 10 → Ch 107 Neuromuscular blocking drugs 1 → Ch 108 Iron deficiency anaemia 1 → Ch 109 Spinal pain transmission 4 → Ch 110 Subarachnoid haemorrhage 4 → Ch 111 Anaphylaxis 3 → Ch 112 Dopamine and prolactin 2 → Ch 113 Cirrhotic ascites 1 → Ch 114 Upper motor neuron lesions 2 → Ch 115 Acute transfusion reactions 4 → Ch 116 Emergency vascular access 1 → Ch 117 Lambert–Eaton myasthenic syndrome 4 → Ch 118 Reversible and irreversible cell injury 2 → Ch 119 Sulfonylurea-induced hypoglycaemia 1 → Ch 120 Complete atrioventricular block 1 → Ch 121 Axillary nerve injury 6 → Ch 122 Antipsychotic-induced acute dystonia 2 → Ch 123 Pyruvate dehydrogenase cofactors 1 → Ch 124 Chronic lymphocytic leukaemia 1 → Ch 125 Hyperkalaemia and ECG changes 2 → Ch 126 Giant cell arteritis 1 → Ch 127 Cancer epidemiology 1 → Ch 128 Amino acid metabolism 1 → Ch 129 Urea cycle disorders 1 → Ch 130 Raised intracranial pressure 2 → Ch 131 Coronary arterial supply 1 → Ch 132 Femoral hernia 1 → Ch 133 Hirschsprung disease 3 → Ch 134 Pulmonary surfactant 1 → Ch 135 Renin–angiotensin–aldosterone system 4 → Ch 136 Autosomal dominant inheritance 1 → Ch 137 Type IV hypersensitivity 6 → Ch 138 G6PD deficiency 3 → Ch 139 Pernicious anaemia 1 → Ch 140 Malaria 1 → Ch 141 Hypoxic pulmonary vasoconstriction 1 → Ch 142 Clostridial myonecrosis 2 → Ch 143 Quantal dose–response relationships 1 → Ch 144 Crohn disease 1 → Ch 145 Thiopental redistribution 1 → Ch 146 Antithyroid treatment in pregnancy 4 → Ch 147 Prepatellar bursitis 2 → Ch 148 Alkaptonuria and homogentisate metabolism 2 → Ch 149 Physiology 1 → Ch 150 Renal Hemodynamics & Glomerular Function 3 → Ch 151 Neurotransmitters & Psychiatry 9 → Ch 152 Medical Microbiology & Infectious Disease 8 → Ch 153 Iron Metabolism & Hemochromatosis 2 → Ch 154 Oncogenesis & Tumor Biology 15 → Ch 155 Rabies post-exposure prophylaxis 2 → Ch 156 Carpal dislocations 1 → Ch 157 Glycocalyx structure and function 1 → Ch 158 Antimuscarinic adverse effects 3 → Ch 159 Hereditary angioedema 3 → Ch 160 Dumping syndrome 2 → Ch 161 Von Willebrand disease 4 → Ch 162 Neural tube defect screening 2 → Ch 163 Cranial nerves in swallowing 1 → Ch 164 Chromatolysis after axonal injury 1 → Ch 165 Oxygen–haemoglobin dissociation curve 4 → Ch 166 Phenylketonuria 3 → Ch 167 Femoral neck fracture complications 2 → Ch 168 Fat embolism syndrome 4 → Ch 169 Facial and cavernous sinus venous connections 2 → Ch 170 Tetanus toxin 1 → Ch 171 Diaphragmatic openings 3 → Ch 172 Antituberculous drugs 4 → Ch 173 Sternal angle landmarks 1 → Ch 174 Hodgkin lymphoma 6 → Ch 175 Asthma controller treatment 4 → Ch 176 Live attenuated vaccines 1 → Ch 177 Osmotic laxatives 1 → Ch 178 Thoracic outlet syndrome 1 → Ch 179 Cardiac cycle and heart sounds 6 → Ch 180 Behçet disease and HLA-B51 2 → Ch 181 Acute appendicitis 1 → Ch 182 Aortic regurgitation 2 → Ch 183 Pneumocystis pneumonia 2 → Ch 184 Gastric cells and secretions 4 → Ch 185 Congenital toxoplasmosis 1 → Ch 186 Burkitt lymphoma 3 → Ch 187 Pleural effusion investigation 1 → Ch 188 Renin–angiotensin blockers and hyperkalaemia 1 → Ch 189 Digoxin effects and toxicity 4 → Ch 190 Pancreatic head and biliary anatomy 1 → Ch 191 Post-dural puncture headache 1 → Ch 192 Androgen physiology 2 → Ch 193 Paranasal sinuses 1 → Ch 194 Thiazolidinedione mechanism 2 → Ch 195 SGLT2 inhibitors in heart failure 1 → Ch 196 Intestinal glucose transport 1 → Ch 197 Autoimmune hepatitis 2 → Ch 198 Herpes zoster treatment 1 → Ch 199 Histograms and continuous data 1 → Ch 200 Asthma diagnosis 1 → Ch 201 Fragile X syndrome 5 → Ch 202 Bulbar palsy and dysphagia 1 → Ch 203 Common fibular nerve injury 5 → Ch 204 Foot inversion muscles 2 → Ch 205 Mucormycosis 4 → Ch 206 Heart failure 2 → Ch 207 Myocardial infarction complications 2 → Ch 208 Pulmonary embolism 1 → Ch 209 Carcinoma in situ 1 → Ch 210 Branchial cleft cyst 1 → Ch 211 Cerebellar Purkinje cells 1 → Ch 212 Vitamin A deficiency 3 → Ch 213 Transamination and glutamate 1 → Ch 214 Fasting glucose homeostasis 6 → Ch 215 Free fatty acid transport 1 → Ch 216 Glucocorticoid metabolic effects 4 → Ch 217 Psychological defence mechanisms 2 → Ch 218 Protein glycosylation and solubility 1 → Ch 219 Initial shock management 2 → Ch 220 Taxane mechanism of action 2 → Ch 221 Forearm supination 2 → Ch 222 Premature ventricular contractions 1 → Ch 223 Lipoproteins and cardiovascular risk 3 → Ch 224 Duodenal arterial relations 3 → Ch 225 Kwashiorkor and oedema 3 → Ch 226 Secretin secretion 2 → Ch 227 Coeliac disease 1 → Ch 228 Hereditary haemochromatosis 3 → Ch 229 Liver embryology 1 → Ch 230 Type I hypersensitivity 8 → Ch 231 Visual adaptation 1 → Ch 232 Hormone second messengers 2 → Ch 233 Sensory discrimination 3 → Ch 234 Haemolytic anaemia 3 → Ch 235 Cerebellar lesion localisation 2 → Ch 236 Midbrain lesion localisation 1 → Ch 237 Bacillus anthracis identification 1 → Ch 238 Necrosis and DNA degradation 1 → Ch 239 NSAID gastrointestinal toxicity 2 → Ch 240 Dorsal column pathways 6 → Ch 241 Sarcoidosis 3 → Ch 242 Anatomical snuffbox 4 → Ch 243 Statistical significance and p-values 1 → Ch 244 Tetralogy of Fallot 3 → Ch 245 Spinal cord vascular syndromes 1 → Ch 246 Insulin metabolic effects 1 → Ch 247 Motor neuron disease anatomy 1 → Ch 248 Acute stroke assessment and treatment 3 → Ch 249 Phenytoin adverse effects 2 → Ch 250 Patient positioning and venous pooling 2 → Ch 251 Gastric arterial supply 2 → Ch 252 Anaerobic glycolysis 1 → Ch 253 Homocystinuria 1 → Ch 254 Primary adrenal insufficiency 7 → Ch 255 Cystic hygroma 1 → Ch 256 Pelvic actinomycosis 1 → Ch 257 Acute pancreatitis 5 → Ch 258 Rhabdomyolysis 1 → Ch 259 Alzheimer disease pathology 3 → Ch 260 Tongue sensory innervation 5 → Ch 261 Transpulmonary pressure 1 → Ch 262 Gastric histology 1 → Ch 263 Streptococcus pneumoniae 2 → Ch 264 Autoimmune polyendocrine syndrome type 1 1 → Ch 265 Geniculate ganglion anatomy 1 → Ch 266 Secondary hyperparathyroidism in CKD 2 → Ch 267 Methotrexate mechanism of action 1 → Ch 268 Acid suppression in Zollinger–Ellison syndrome 1 → Ch 269 Beta blockers in hyperthyroidism 1 → Ch 270 Small intestinal diarrhoea 1 → Ch 271 Arterial and venous blood gas comparison 1 → Ch 272 Rheumatic mitral stenosis 3 → Ch 273 Agonist efficacy and dose–response curves 2 → Ch 274 Autosomal dominant polycystic kidney disease 2 → Ch 275 Congenital adrenal hyperplasia 3 → Ch 276 Hypertrophic cardiomyopathy 2 → Ch 277 Glucocorticoid-induced osteoporosis 2 → Ch 278 Acute angle-closure glaucoma 1 → Ch 279 Parotid tumours and facial nerve involvement 1 → Ch 280 Principles of medical ethics 1 → Ch 281 Dengue fever 2 → Ch 282 Kawasaki disease 1 → Ch 283 Intercostal neurovascular bundles 1 → Ch 284 Antipsychotic adverse effects 1 → Ch 285 Tuberculin skin test interpretation 1 → Ch 286 Mycoplasma pneumoniae immunity 1 → Ch 287 Malaria blood-stage treatment 1 → Ch 288 FSH and follicular maturation 1 → Ch 289 Carbon monoxide poisoning and pulse oximetry 4 → Ch 290 Anti-glomerular basement membrane disease 1 → Ch 291 Worldwide cancer incidence in men 1 → Ch 292 Wolff–Parkinson–White syndrome 1 → Ch 293 Phenobarbital poisoning and urinary alkalinisation 1 → Ch 294 Electron transport chain inhibitors 3 → Ch 295 Subacute granulomatous thyroiditis 1 → Ch 296 Secretory IgA transport 2 → Ch 297 Familial chylomicronaemia 2 → Ch 298 Acute inflammation and wound healing 1 → Ch 299 Thiamine deficiency and Wernicke–Korsakoff syndrome 4 → Ch 300 Niacin deficiency 3 → Ch 301 Vitamin B12 deficiency after gastrectomy 2 → Ch 302 Metformin-associated vitamin B12 deficiency 1 → Ch 303 Hepatocellular carcinoma and AFP 4 → Ch 304 Neonatal surfactant deficiency 3 → Ch 305 Gram-negative outer membrane and endotoxin 1 → Ch 306 Pattern recognition in innate immunity 1 → Ch 307 Endothelial glycocalyx charge 1 → Ch 308 Zollinger–Ellison syndrome investigation 1 → Ch 309 Distal radius fractures 1 → Ch 310 Direct thrombin inhibitors 1 → Ch 311 Direct factor Xa inhibitors 1 → Ch 312 Factor XIII deficiency 1 → Ch 313 Allopurinol mechanism of action 1 → Ch 314 Gaucher disease 2 → Ch 315 High-altitude pulmonary oedema 1 → Ch 316 Duodenal anatomical relations 1 → Ch 317 Normal-pressure hydrocephalus 1 → Ch 318 Cushing syndrome screening 2 → Ch 319 X-linked agammaglobulinaemia 2 → Ch 320 Eyelid glands and hordeolum 1 → Ch 321 Serotonin and noradrenaline reuptake inhibitors 1 → Ch 322 Fetal lung maturity assessment 1 → Ch 323 CEA in colorectal cancer follow-up 2 → Ch 324 IgA vasculitis 2 → Ch 325 Deep neck infection spread 2 → Ch 326 Plantaris and Achilles tendon injuries 1 → Ch 327 Olfactory cortex 1 → Ch 328 Sigmoid colon arterial supply 1 → Ch 329 Nucleotide structure 1 → Ch 330 DNA base pairing 1 → Ch 331 Amniotic fluid volume 1 → Ch 332 LH surge and ovulation prediction 3 → Ch 333 Endocrine treatment of breast cancer 2 → Ch 334 Isoniazid adverse effects 5 → Ch 335 Proteus urinary infection 2 → Ch 336 Candidiasis 4 → Ch 337 Cryptococcal meningitis induction therapy 1 → Ch 338 Haemangioma 1 → Ch 339 Theophylline mechanism of action 2 → Ch 340 Finasteride mechanism and adverse effects 1 → Ch 341 Gastric cancer clinical signs 1 → Ch 342 Terminal bronchiole epithelium 1 → Ch 343 Facial sympathetic innervation 2 → Ch 344 Primary sclerosing cholangitis 1 → Ch 345 Magnesium sulfate in pre-eclampsia and eclampsia 1 → Ch 346 Hypokalaemic periodic paralysis 1 → Ch 347 Atrial shunts and paradoxical embolism 1 → Ch 348 Thyroidectomy complications 1 → Ch 349 Flexor retinaculum attachments 1 → Ch 350 Ankle reflex and S1 radiculopathy 1 → Ch 351 Osteomyelitis in sickle cell disease 1 → Ch 352 Clostridioides difficile treatment 2 → Ch 353 Invasive amoebiasis treatment 2 → Ch 354 Hepatic hydatid disease diagnosis 1 → Ch 355 Cerebral toxoplasmosis in HIV 1 → Ch 356 Dysthyroid optic neuropathy 2 → Ch 357 Antihypertensives in pregnancy 1 → Ch 358 Methotrexate in rheumatoid arthritis 1 → Ch 359 Renal bicarbonate reabsorption 1 → Ch 360 XYY and nondisjunction 1 → Ch 361 Bronchiectasis imaging 1 → Ch 362 Coronary thrombosis in acute myocardial infarction 3 → Ch 363 Cardiac biomarkers 3 → Ch 364 Ventricular fibrillation resuscitation 1 → Ch 365 Chi-square test 1 → Ch 366 Acute symptomatic hypocalcaemia 1 → Ch 367 Facial nerve lesion localisation 1 → Ch 368 Lipiduria in nephrotic syndrome 1 → Ch 369 Parkinson disease 2 → Ch 370 Acromegaly investigation 2 → Ch 371 Coronary sinus pacing 1 → Ch 372 Anterior cardiac surface 1 → Ch 373 Limited systemic sclerosis antibodies 1 → Ch 374 Primary hyperaldosteronism 2 → Ch 375 Bile acid conjugation 1 → Ch 376 Antibiotics and Clostridioides difficile risk 2 → Ch 377 Mental nerve sensory territory 1 → Ch 378 Duchenne muscular dystrophy 4 → Ch 379 Malaria hypnozoite eradication 4 → Ch 380 Immune tolerance 1 → Ch 381 Corynebacterium diphtheriae morphology 1 → Ch 382 Follicular thyroid carcinoma spread 3 → Ch 383 Parkinson disease pathology 4 → Ch 384 Scarlet fever 2 → Ch 385 Urgent renal replacement therapy 1 → Ch 386 Gallbladder pain pathways 1 → Ch 387 Drug potency and efficacy 1 → Ch 388 Fat malabsorption and vitamin D deficiency 1 → Ch 389 Giardiasis 1 → Ch 390 Barrett oesophagus 4 → Ch 391 Endometrial inflammation 1 → Ch 392 Carrier-mediated transport saturation 2 → Ch 393 Liquefactive necrosis of the brain 2 → Ch 394 Lithium-induced nephrogenic diabetes insipidus 1 → Ch 395 Grapefruit and CYP3A4 drug interactions 1 → Ch 396 Aortic stenosis and pulse pressure 1 → Ch 397 Liquefactive necrosis in brain abscess 1 → Ch 398 Frank–Starling mechanism 3 → Ch 399 Superior gluteal nerve and Trendelenburg gait 1 → Ch 400 Open-angle glaucoma 1 → Ch 401 Thrombolytic mechanisms and selection 5 → Ch 402 Diabetes diagnosis in pregnancy 1 → Ch 403 Huntington disease and anticipation 2 → Ch 404 Ventricular fibrillation 1 → Ch 405 Pantothenic acid and coenzyme A 1 → Ch 406 Tuberculous peritonitis 2 → Ch 407 Gastrointestinal cancer prognosis 1 → Ch 408 Breast cancer risk factors 1 → Ch 409 Proto-oncogenes and carcinogenesis 2 → Ch 410 Ventilation–perfusion relationships 6 → Ch 411 Vitamin D metabolism and deficiency 5 → Ch 412 Caseous necrosis 1 → Ch 413 Klinefelter syndrome 1 → Ch 414 Azole antifungals 2 → Ch 415 Parietal cortex and sensory neglect 2 → Ch 416 Sodium–potassium ATPase 1 → Ch 417 Antidepressant-induced hyponatraemia 1 → Ch 418 Legionella pneumonia 2 → Ch 419 Herpes simplex meningitis 1 → Ch 420 Hepatic abscess 2 → Ch 421 Gluteus maximus and hip extension 1 → Ch 422 Down syndrome 4 → Ch 423 Tuberculous meningitis 1 → Ch 424 Enterohepatic circulation of bile salts 2 → Ch 425 Gallstones 2 → Ch 426 Baroreceptor reflex 4 → Ch 427 Brainstem respiratory control 2 → Ch 428 Femoral canal anatomy 3 → Ch 429 Accessory respiratory muscles 4 → Ch 430 Laryngeal nerve injuries 2 → Ch 431 Thiamine deficiency and beriberi 1 → Ch 432 Raynaud phenomenon treatment 1 → Ch 433 Chronic granulomatous disease 1 → Ch 434 Cardiovascular changes in pregnancy 1 → Ch 435 Hypothalamic–pituitary–thyroid feedback 4 → Ch 436 Aplastic anaemia 2 → Ch 437 Folate deficiency 1 → Ch 438 Central and peripheral cyanosis 1 → Ch 439 Brown-Séquard syndrome 3 → Ch 440 Radial nerve injury 4 → Ch 441 Astigmatism 1 → Ch 442 Ankylosing spondylitis and HLA-B27 1 → Ch 443 IL-12–IFN-γ pathway 1 → Ch 444 Phrenic nerve 1 → Ch 445 Thyroid hormone metabolic effects 1 → Ch 446 Cushing syndrome 3 → Ch 447 Cardiac parasympathetic effects 1 → Ch 448 Appendicular arterial supply 1 → Ch 449 Optic chiasm and pituitary lesions 4 → Ch 450 Unconjugated hyperbilirubinaemia 4 → Ch 451 Proprioceptive sensory fibres 1 → Ch 452 Molecular diagnosis of infection 1 → Ch 453 Immunoglobulin classes 6 → Ch 454 Granulomatosis with polyangiitis 1 → Ch 455 Salivary glands and sialolithiasis 1 → Ch 456 Colonic water and electrolyte absorption 1 → Ch 457 Lupus nephritis classification 2 → Ch 458 GABA and neuronal inhibition 1 → Ch 459 Visual cortex localisation 1 → Ch 460 Optic radiations and visual field defects 1 → Ch 461 Gonadal development 1 → Ch 462 Lactation hormones 1 → Ch 463 Acute aortic dissection management 3 → Ch 464 ECG changes after myocardial infarction 3 → Ch 465 Supraventricular tachycardia 1 → Ch 466 Coarctation of the aorta 1 → Ch 467 Papillary thyroid carcinoma 2 → Ch 468 Club cells and bronchiolar repair 1 → Ch 469 Renal plasma flow measurement 2 → Ch 470 Growth hormone and somatotrophs 2 → Ch 471 Ehlers–Danlos syndrome 1 → Ch 472 Drug half-life and dosing interval 3 → Ch 473 Toxicology screening 1 → Ch 474 Ulcerative colitis 2 → Ch 475 Methotrexate pulmonary toxicity 1 → Ch 476 Metformin mechanism of action 2 → Ch 477 SGLT2 inhibitors and ketoacidosis 1 → Ch 478 Cohort studies 1 → Ch 479 Cholinesterase inhibitors in Alzheimer disease 1 → Ch 480 CSF shunt infections 1 → Ch 481 Vesicoureteral reflux 1 → Ch 482 Streptococcal pharyngitis 1 → Ch 483 Coronary sinus drainage 1 → Ch 484 Helicobacter pylori and duodenal ulceration 1 → Ch 485 Stable wide-complex tachycardia 1 → Ch 486 Suppurative inflammation 1 → Ch 487 Uraemia and CKD mineral disturbances 1 → Ch 488 Acute variceal bleeding 3 → Ch 489 Aortic stenosis and myocardial ischaemia 2 → Ch 490 Hepatic encephalopathy treatment 1 → Ch 491 Androgen insensitivity syndrome 2 → Ch 492 Allantois and urachus 1 → Ch 493 Garlic and cholesterol metabolism 1 → Ch 494 Spinocerebellar pathways 2 → Ch 495 Tuberculous granulomas 1 → Ch 496 Vitamin B12 deficiency 4 → Ch 497 Breast cancer receptor testing 1 → Ch 498 Antenatal aneuploidy screening 1 → Ch 499 Endometrial hyperplasia 1 → Ch 500 Pre-eclampsia 1 → Ch 501 Beta-blockers in decompensated cirrhosis 1 → Ch 502 Ciliary ganglion and ocular parasympathetics 2 → Ch 503 Oculocardiac reflex 1 → Ch 504 Hypertensive retinopathy 1 → Ch 505 Anaemia of chronic disease 1 → Ch 506 Nucleus tractus solitarius 1 → Ch 507 Uric acid stones 2 → Ch 508 Primary Raynaud phenomenon 1 → Ch 509 Thromboangiitis obliterans 1 → Ch 510 Varicella pneumonia 1 → Ch 511 Breast milk composition 1 → Ch 512 Peripheral arterial disease investigation 1 → Ch 513 Dietary fibre intake 1 → Ch 514 Portosystemic anastomoses 3 → Ch 515 Varicocele and gonadal venous drainage 2 → Ch 516 Tarsal tunnel syndrome 1 → Ch 517 Fertilisation and polyspermy prevention 1 → Ch 518 ACE inhibitor adverse effects 1 → Ch 519 Ketone testing during DKA treatment 1 → Ch 520 Adenosine and bronchospasm 1 → Ch 521 Visceral leishmaniasis 1 → Ch 522 Torsades de pointes 2 → Ch 523 Fluoroquinolone mechanism of action 1 → Ch 524 Quadriceps and knee extension 1 → Ch 525 Heat exposure and sodium disturbances 1 → Ch 526 Information disclosure 1 → Ch 527 Atrial contraction and cardiac output 1 → Ch 528 Cirrhosis 1 → Ch 529 Helminths and eosinophilia 1 → Ch 530 Achondroplasia inheritance 1 → Ch 531 Echinococcus life cycle 1 → Ch 532 Meningococcaemia and adrenal haemorrhage 1 → Ch 533 Lactational amenorrhoea 1 → Ch 534 Helicobacter pylori testing 1 → Ch 535 Diaphragmatic referred pain 2 → Ch 536 Upper brachial plexus injury 1 → Ch 537 Listeria meningitis 1 → Ch 538 Benign prostatic hyperplasia 3 → Ch 539 Alpha blockers in benign prostatic hyperplasia 1 → Ch 540 Idiopathic intracranial hypertension 3 → Ch 541 Constipation and bulk-forming laxatives 1 → Ch 542 Randomisation and blinding in clinical trials 1 → Ch 543 Amiodarone pulmonary toxicity 2 → Ch 544 Clinical trial outcome domains 1 → Ch 545 Generalised tonic–clonic seizures 2 → Ch 546 Aerobic glucose oxidation and ATP yield 1 → Ch 547 B-cell lymphoma treatment 1 → Ch 548 ADH and renal water reabsorption 1 → Ch 549 Systemic lupus erythematosus 4 → Ch 550 Systemic juvenile idiopathic arthritis 1 → Ch 551 Dermatomyositis 1 → Ch 552 Dilated cardiomyopathy 1 → Ch 553 Smooth pursuit eye movements 1 → Ch 554 Hookworm and iron deficiency 1 → Ch 555 Acute rheumatic fever 1 → Ch 556 Brain fuel metabolism 1 → Ch 557 Polycystic ovary syndrome diagnosis 1 → Ch 558 Lithium exposure and Ebstein anomaly 1 → Ch 559 Drug tolerance 1 → Ch 560 SGLT2 inhibitor mechanism 1 → Ch 561 Acute hyperkalaemia management 1 → Ch 562 Sucralfate mechanism of action 1 → Ch 563 Glial tumour immunohistochemistry 1 → Ch 564 Bone mineral density assessment 1 → Ch 565 Paget disease of bone 2 → Ch 566 Mast cell stabilisers 2 → Ch 567 Dobutamine pharmacology 1 → Ch 568 Paroxysmal nocturnal haemoglobinuria 1 → Ch 569 Neutrophil granules 1 → Ch 570 Forced expiration muscles 1 → Ch 571 Facial nerve in the parotid gland 1 → Ch 572 Lateral pterygoid and the TMJ 1 → Ch 573 Tumour suppressor genes 1 → Ch 574 Acute gouty arthritis 1 → Ch 575 Hypoglossal nucleus and medullary lesions 1 → Ch 576 Insulin and potassium distribution 1 → Ch 577 T-cell-mediated autoimmunity 1 → Ch 578 Type 1 diabetes autoantibodies 1 → Ch 579 Magnesium sulfate toxicity monitoring 1 → Ch 580 Migraine 1 → Ch 581 Spinal dysraphism 1 → Ch 582 Primary ciliary dyskinesia 1 → Ch 583 Lipid oxidation and rancidity 2 → Ch 584 Acanthosis nigricans 2 → Ch 585 STEMI reperfusion 4 → Ch 586 Posterior epistaxis arterial supply 2 → Ch 587 Tetanus management 2 → Ch 588 Tuberous sclerosis complex 2 → Ch 589 Steady-state pharmacokinetics 1 → Ch 590 Glomerulonephritis and urinary casts 2 → Ch 591 Immune thrombocytopenia 2 → Ch 592 Functional neurological disorder 2 → Ch 593 Persistent or recurrent urethritis 3 → Ch 594 Transfusional iron overload 2 → Ch 595 Benign paroxysmal positional vertigo 2 → Ch 596 Placental nutrient transport 1 → Ch 597 Kyphosis 1 → Ch 598 Porphyria cutanea tarda 3 → Ch 599 Bernard–Soulier syndrome 1 → Ch 600 Bacillus cereus food poisoning 1 → Ch 601 Investigation of altered bowel habit 1 → Ch 602 Bleeding with normal screening tests 1 → Ch 603 Co-trimoxazole synergism 1 → Ch 604 Tabes dorsalis 1 → Ch 605 Tumour growth kinetics 1 → Ch 606 Autonomic control of erection 1 → Ch 607 Hypertensive cardiac hypertrophy 1 → Ch 608 Viral meningitis 1 → Ch 609 Alpha-1 adrenergic receptors 2 → Ch 610 Arterial and venous haemodynamics 1 → Ch 611 Hypoxia and erythropoietin 1 → Ch 612 Decompression sickness 1 → Ch 613 hCG and corpus luteum maintenance 2 → Ch 614 Gonorrhoea treatment 1 → Ch 615 RhD alloimmunisation prevention 2 → Ch 616 Hereditary spherocytosis 3 → Ch 617 Chromosomal causes of recurrent pregnancy loss 1 → Ch 618 Post-streptococcal glomerulonephritis 2 → Ch 619 Atrial fibrillation 3 → Ch 620 Pulmonary hypertension haemodynamics 1 → Ch 621 Patent ductus arteriosus 5 → Ch 622 Renal autoregulation 2 → Ch 623 Phaeochromocytoma cellular origin 1 → Ch 624 Bartholin gland cyst 1 → Ch 625 Pericardiocentesis access 2 → Ch 626 Oxygen-induced hypercapnia in COPD 1 → Ch 627 Pancreatic head carcinoma 2 → Ch 628 Interface hepatitis 1 → Ch 629 Carotid bifurcation anatomy 2 → Ch 630 Accommodation and presbyopia 2 → Ch 631 Pulmonary aspergilloma 1 → Ch 632 Thoracodorsal nerve and latissimus dorsi 1 → Ch 633 Noise-induced hearing loss 1 → Ch 634 Hydatidiform mole 1 → Ch 635 Tibial nerve and plantar flexion 1 → Ch 636 Trigeminal neuralgia 1 → Ch 637 Glucocorticoid anti-inflammatory mechanisms 1 → Ch 638 Chronic obstructive pulmonary disease 1 → Ch 639 Renal venous drainage 1 → Ch 640 Alzheimer disease 1 → Ch 641 Meralgia paraesthetica 2 → Ch 642 Renal actions of parathyroid hormone 1 → Ch 643 Warfarin food interactions 1 → Ch 644 Jugular foramen and cranial nerves 1 → Ch 645 Parenteral nutrition 1 → Ch 646 Triptan mechanism of action 1 → Ch 647 Levodopa metabolism and adverse effects 1 → Ch 648 Growth hormone resistance 1 → Ch 649 Thyroid carcinoma metastases 1 → Ch 650 Acute viral hepatitis 1 → Ch 651 Hyposplenism and Howell–Jolly bodies 1 → Ch 652 Enterobiasis treatment 1 → Ch 653 Kaplan–Meier survival analysis 1 → Ch 654 Circadian rhythm regulation 2 → Ch 655 FSH and spermatogenesis 1 → Ch 656 Chronic benzodiazepines and anaesthetic requirements 1 → Ch 657 Intracerebral haemorrhage and raised intracranial pressure 2 → Ch 658 Autoimmune polyendocrine syndrome type 2 1 → Ch 659 PRPP synthetase superactivity 1 → Ch 660 Whipple disease 3 → Ch 661 Malaria diagnosis 2 → Ch 662 Alcohol-associated hepatitis 1 → Ch 663 Ester local anaesthetic metabolism 1 → Ch 664 Renal cell carcinoma 2 → Ch 665 Zollinger–Ellison syndrome 1 → Ch 666 Wiskott–Aldrich syndrome 1 → Ch 667 Supraspinatus and shoulder abduction 1 → Ch 668 Syndrome of inappropriate ADH secretion 1 → Ch 669 Asbestosis 1 → Ch 670 Insulinoma 1 → Ch 671 Hepatitis B virology 1 → Ch 672 Oesophageal carcinoma 2 → Ch 673 Bladder carcinoma 2 → Ch 674 Secondary immunodeficiency 1 → Ch 675 Anorexia nervosa 1 → Ch 676 Praziquantel mechanism of action 1 → Ch 677 Eosinophilic oesophagitis 1 → Ch 678 Nasal lymphatic drainage 1 → Ch 679 Intestinal taeniasis treatment 1 → Ch 680 Fish tapeworm and vitamin B12 deficiency 1 → Ch 681 Sciatic nerve and posterior hip dislocation 1 → Ch 682 Antibiotic selection in renal impairment 2 → Ch 683 Bacterial dysentery 1 → Ch 684 Vitamin E and antioxidant function 1 → Ch 685 Essential and conditionally essential amino acids 1 → Ch 686 Vitamin C and collagen synthesis 2 → Ch 687 Enzymatic fat necrosis 1 → Ch 688 Thiamine-dependent pyruvate metabolism 1 → Ch 689 Alveolar macrophages and septal structure 1 → Ch 690 Local metabolic regulation of blood flow 1 → Ch 691 Respiration and venous return 1 → Ch 692 Antithyroid drug selection 1 → Ch 693 Dementia assessment 1 → Ch 694 Caloric restriction and cellular ageing 1 → Ch 695 Xiphoid surface anatomy 1 → Ch 696 Maxillary nerve sensory territory 1 → Ch 697 Cutaneous sensory receptors 1 → Ch 698 Aspiration pneumonia 1 → Ch 699 Menkes disease 2 → Ch 700 Fibroadenoma 1 → Ch 701 Antibody deficiency syndromes 1 → Ch 702 Long bone ossification 1 → Ch 703 Post-maturity syndrome 1 → Ch 704 Femoral triangle neurovascular arrangement 1 → Ch 705 Inflammatory mediators and markers 1 → Ch 706 Heparin-induced thrombocytopenia 2 → Ch 707 Potassium shifts during exercise 1 → Ch 708 Intestinal M cells and antigen sampling 1 → Ch 709 Tuberculous pleural effusion 1 → Ch 710 Haemophilia and coagulation testing 1 → Ch 711 Processus vaginalis and cryptorchidism 1 → Ch 712 Mast cell mediators 1 → Ch 713 Acute pulmonary oedema treatment 2 → Ch 714 Sympathetic neurotransmission in the heart 1 → Ch 715 Skeletal muscle tetanus 1 → Ch 716 Serotonin and intestinal motility 1 → Ch 717 Oesophageal spasm treatment 1 → Ch 718 Dominant parietal lobe functions 1 → Ch 719 Salicylate poisoning treatment 1 → Ch 720 Skeletal muscle connective tissue 1 → Ch 721 Metaplasia 3 → Ch 722 Acute red eye assessment 1 → Ch 723 ACE inhibitors and cardiac afterload 1 → Ch 724 Nelson syndrome 1 → Ch 725 Nissl substance 1 → Ch 726 Lactose intolerance 1 → Ch 727 Shock haemodynamics 1 → Ch 728 Sleep stages and neurotransmitters 1 → Ch 729 Autonomic dysreflexia 1 → Ch 730 Haemodialysis dialysate 1 → Ch 731 Dietary fat and chylomicrons 1 → Ch 732 Comparison of group means 2 → Ch 733 Sensory modalities 1 → Ch 734 Plasma protein binding 1 → Ch 735 Health belief model 1 → Ch 736 Metanephric kidney development 1 → Ch 737 Colliculi and auditory orienting 1 → Ch 738 Glucocorticoid effects on leukocytes 1 → Ch 739 Hepatitis B diagnostic markers 2 → Ch 740 Staphylococcal toxic shock syndrome 1 → Ch 741 Subdural haematoma and bridging veins 1 → Ch 742 Pre-renal azotaemia 1 → Ch 743 Hypothalamic appetite regulation 2 → Ch 744 Glucagon during exercise 1 → Ch 745 Tissue factor and extrinsic coagulation 1 → Ch 746 Secondary syphilis 1 → Ch 747 Parotid parasympathetic innervation 2 → Ch 748 Primary hyperparathyroidism 2 → Ch 749 Cytochrome P450 drug interactions 1 → Ch 750 Dietary management of obesity 1 → Ch 751 Fetal and maternal placental components 1 → Ch 752 Lateral ankle ligament injuries 1 → Ch 753 Deep venous thrombosis 1 → Ch 754 Haematological changes in pregnancy 1 → Ch 755 Peripheral resistance and arterial pressure 1 → Ch 756 Thoracic duct drainage 1 → Ch 757 Statin mechanism of action 1 → Ch 758 30S ribosomal antibiotics 1 → Ch 759 Organ blood flow autoregulation 1 → Ch 760 Dystrophic calcification 1 → Ch 761 T-cell-mediated graft rejection 1 → Ch 762 Hippocampus and memory formation 1 → Ch 763 MHC antigen presentation 1 → Ch 764 Central chemoreceptor physiology 2 → Ch 765 Vagal control of gastric function 2 → Ch 766 Parotid superficial relations 1 → Ch 767 Mesangial clearance of immune complexes 1 → Ch 768 Hypercalcaemia of malignancy treatment 1 → Ch 769 Recurrent streptococcal pharyngitis treatment 1 → Ch 770 Viral cell injury 1 → Ch 771 Nephron diluting segments 1 → Ch 772 Von Gierke disease 2 → Ch 773 Anthracosis and coal dust exposure 2 → Ch 774 Dysplasia and malignant behaviour 1 → Ch 775 Ivermectin and onchocerciasis 1 → Ch 776 Upper limb dermatomes 1 → Ch 777 Sympathetic innervation of sweat glands 1 → Ch 778 Nocardia identification 1 → Ch 779 Antituberculous dosing in renal impairment 1 → Ch 780 Ewing sarcoma translocation 1 → Ch 781 ABO and Rh blood grouping 1 → Ch 782 Pelvic fracture and urinary tract injury 2 → Ch 783 Countercurrent multiplication 1 → Ch 784 Vasoactive inflammatory mediators 1 → Ch 785 Normal ECG assessment 1 → Ch 786 Bleeding and nutritional deficiency in pregnancy 1 → Ch 787 Foreign-body granulomatous inflammation 1 → Ch 788 Amantadine for levodopa-induced dyskinesia 1 → Ch 789 Hering–Breuer inflation reflex 1 → Ch 790 Testicular ischaemic necrosis 1 → Ch 791 Sour taste transduction 2 → Ch 792 Trochanteric and cruciate anastomoses 1 → Ch 793 P-glycoprotein drug efflux 1 → Ch 794 Antihypertensive selection in diabetes 1 → Ch 795 Pterion and middle meningeal artery 1 → Ch 796 Histamine synthesis 2 → Ch 797 Thyroid hormone synthesis 1 → Ch 798 Cremasteric reflex 1 → Ch 799 Protein synthesis and memory consolidation 1 → Ch 800 Sickle cell inheritance 1 → Ch 801 RB tumour suppressor gene 1 → Ch 802 Surgical prophylaxis and antibiotic allergy 1 → Ch 803 Tetracyclines and tooth staining 1 → Ch 804 Trisomy 13 1 → Ch 805 Lead poisoning and haem synthesis 3 → Ch 806 Cholestatic liver enzyme pattern 1 → Ch 807 Deep venous thrombosis investigation 1 → Ch 808 Early syphilis treatment 1 → Ch 809 D-dimer in pulmonary embolism assessment 1 → Ch 810 Retinal arterial supply and ocular trauma 1 → Ch 811 Herpes simplex keratitis 1 → Ch 812 Cyclophosphamide haemorrhagic cystitis 1 → Ch 813 Complement-mediated chemotaxis 1 → Ch 814 Urinary stone imaging 2 → Ch 815 Diabetic vascular injury mechanisms 1 → Ch 816 Myelodysplastic syndrome 1 → Ch 817 Barr bodies and sex chromosome number 1 → Ch 818 G6PD deficiency inheritance 1 → Ch 819 SDH-related tumour predisposition inheritance 1 → Ch 820 Mycoplasma cell wall absence 1 → Ch 821 Enteral nutrients and gastrointestinal hormones 1 → Ch 822 Retinal pigment epithelium functions 1 → Ch 823 Streptomycin ototoxicity 1 → Ch 824 Precocious puberty and adult height 1 → Ch 825 Salivary mucins 1 → Ch 826 Collagen in wound healing 1 → Ch 827 BK polyomavirus after renal transplantation 1 → Ch 828 Malaria life cycle 1 → Ch 829 Clostridial characteristics 1 → Ch 830 Disseminated intravascular coagulation 1 → Ch 831 Cell Cycle and Mitosis 1 → Ch 832 Vitamin B1 Deficiency 1 → Ch 833 Vitamin Deficiency in Pancreatitis 1 → Ch 834 Fibrates 1 → Ch 835 Temporal Bone 2 → Ch 836 Thyroid Carcinoma 1 → Ch 837 Medullary Thyroid Carcinoma 2 → Ch 838 Chromosome Structure 1 → Ch 839 Erythrocyte Physiology 1 → Ch 840 Pheochromocytoma 3 → Ch 841 Antimalarial Adverse Effects 1 → Ch 842 Antimicrobial Mechanisms 1 → Ch 843 Renal Drug Clearance 1 → Ch 844 DNA Damage and Repair 1 → Ch 845 Metronidazole 1 → Ch 846 Taste Transduction 1 → Ch 847 Upper Motor Neuron Facial Weakness 1 → Ch 848 Amoebic Dysentery 1 → Ch 849 Focal Seizures 1 → Ch 850 Glucocorticoid Actions 1 → Ch 851 Lambert-Eaton Syndrome 1 → Ch 852 Compound Action Potential 1 → Ch 853 Paraneoplastic Syndromes 1 → Ch 854 Splenic Injury 1 → Ch 855 Hypocalcemia 1 → Ch 856 Acromegaly 1 → Ch 857 Pituitary Adenoma 1 → Ch 858 Hypothyroidism 1 → Ch 859 Hemorrhagic Ascites 1 → Ch 860 Virchow Triad 1 → Ch 861 Hepatitis B 1 → Ch 862 Post-thyroidectomy Hypocalcemia 2 → Ch 863 Midbrain Syndromes 1 → Ch 864 Trochlear Nerve Palsy 1 → Ch 865 Glyoxylate and Oxalate Metabolism 1 → Ch 866 Metformin-associated Lactic Acidosis 1 → Ch 867 SGLT2 Inhibitors 1 → Ch 868 Cavernous Sinus 1 → Ch 869 Calcineurin Inhibitors 1 → Ch 870 Hookworm Infection 1 → Ch 871 Diabetic Autonomic Neuropathy 1 → Ch 872 Xeroderma Pigmentosum 1 → Ch 873 Ectopic ACTH Syndrome 2 → Ch 874 Cytoskeleton 1 → Ch 875 Salivary Glands 1 → Ch 876 Complement System 1 → Ch 877 Liquefactive Necrosis 1 → Ch 878 Functional Residual Capacity 3 → Ch 879 Hepatitis C 1 → Ch 880 Scaphoid Injury 1 → Ch 881 Internal Capsule Stroke 1 → Ch 882 Growth Hormone Regulation 1 → Ch 883 Secretin 1 → Ch 884 Follicular Thyroid Carcinoma 1 → Ch 885 Premalignant Cellular Changes 1 → Ch 886 Pernicious Anemia 1 → Ch 887 Obstructive Lung Disease 1 → Ch 888 Hippocampus 1 → Ch 889 Posterior Pituitary Hormones 1 → Ch 890 Kupffer Cells 1 → Ch 891 Stomodeum 1 → Ch 892 Hypothalamic Temperature Regulation 1 → Ch 893 Ketamine Interactions 1 → Ch 894 Type 2 Diabetes Mellitus 1 → Ch 895 Malignant Otitis Externa 1 → Ch 896 Raynaud Phenomenon 2 → Ch 897 First Heart Sound 1 → Ch 898 Polycythemia Vera 1 → Ch 899 Lower Motor Neuron Lesion 1 → Ch 900 Perioperative Thyrotoxicosis 1 → Ch 901 Splenic Artery 1 → Ch 902 Brunner Glands 1 → Ch 903 Diarrhea Localization 1 → Ch 904 Resting Membrane Potential 1 → Ch 905 Femoral Region 1 → Ch 906 Cardiac Hypertrophy 1 → Ch 907 Lateral Pterygoid 1 → Ch 908 Sildenafil and Nitrates 1 → Ch 909 Prediabetes 1 → Ch 910 Left Coronary Artery 2 → Ch 911 Touch and Pressure Fibers 1 → Ch 912 Oxygen-Hemoglobin Dissociation Curve 1 → Ch 913 Middle Cerebral Artery Stroke 1 → Ch 914 Mesothelioma 1 → Ch 915 Prerenal Azotemia 1 → Ch 916 Acetazolamide 1 → Ch 917 Wilson Disease 2 → Ch 918 Iron Transport 1 → Ch 919 Proximal Tubular Reabsorption 2 → Ch 920 Glucose Reabsorption 1 → Ch 921 Clostridioides difficile Infection 1 → Ch 922 ADH 1 → Ch 923 Aldosterone 1 → Ch 924 Medical Confidentiality 1 → Ch 925 Sacral Nerve Root Injury 1 → Ch 926 Ventricular Ejection 1 → Ch 927 Exercise and Oxygen Unloading 1 → Ch 928 Fetal Erythropoiesis 1 → Ch 929 Intravascular Hemolysis 1 → Ch 930 Bilirubin Conjugation 1 → Ch 931 Occupational Asthma 1 → Ch 932 Obstructive Spirometry 1 → Ch 933 Acute Stress Response 1 → Ch 934 von Willebrand Factor 1 → Ch 935 Facial Artery 1 → Ch 936 Indirect Inguinal Hernia 2 → Ch 937 Hyperthyroidism in Pregnancy 1 → Ch 938 Plasma Oncotic Pressure 1 → Ch 939 Buccopharyngeal Fascia 1 → Ch 940 Newborn Chest 1 → Ch 941 Platelet Transfusion Refractoriness 1 → Ch 942 Cardiogenic Pulmonary Edema 1 → Ch 943 Lateral Ankle Sprain 1 → Ch 944 Rate Control in Hyperthyroidism 1 → Ch 945 Applied Anatomy 51 → Ch 946 Clinical Medicine 61 → Ch 947 General & Systemic Pathology 24 → Ch 948 Integrated Physiology 11 → Ch 949 Metabolism & Molecular Biology 22 → Ch 950 Microbiology & Immunology 5 → Ch 951 General & Clinical Pharmacology 12 → Ch 952 General Medicine 60 → Ch 953 Bacteriology 7 → Ch 954 Virology & Parasitology 7 → Ch 955 Pregnancy & Gynaecology 7 → Ch 956 Metabolic Disorders 2 → Ch 957 Muscle Physiology 2 → Ch 958 Clinical Pharmacology 14 → Ch 959 Renal Physiology 4 → Ch 960 Cardiovascular Physiology 9 → Ch 961 Clinical Immunology 9 → Ch 962 Anaemia & Haematology 6 → Ch 963 Inheritance & Chromosomal Disorders 8 → Ch 964 Neurophysiology 4 → Ch 965 Head 4 → Ch 966 Neck & Pelvic Anatomy 4 → Ch 967 Pulmonary Disorders 1 → Ch 968 Embryology 5 → Ch 969 Prostate Disease 1 → Ch 970 Metabolism & Enzymes 6 → Ch 971 Respiratory Physiology 9 → Ch 972 Renal Disorders 2 → Ch 973 Thyroid Disorders 1 → Ch 974 Biostatistics 1 → Ch 975 Headache Disorders 1 → Ch 976 Tinea Corporis 2 → Ch 977 Celiac Disease / D-Xylose Test 2 → Ch 978 Inferior STEMI / Right Coronary Artery 1 → Ch 979 Monozygotic Twin Chorionicity 1 → Ch 980 Carbamazepine Enzyme Induction 2 → Ch 981 Cardiac Axis on ECG 1 → Ch 982 Sarcoidosis Granuloma Formation 1 → Ch 983 Terminal Complement Deficiency 1 → Ch 984 Inguinal Region Anatomy 2 → Ch 985 Acute Pancreatitis Imaging 2 → Ch 986 Clostridioides difficile Colitis 3 → Ch 987 Ventricular Fibrillation / Defibrillation 2 → Ch 988 Alzheimer Disease Pharmacotherapy 2 → Ch 989 Leishmaniasis 2 → Ch 990 Gonadal Radiation Injury 1 → Ch 991 Dyspepsia / Peptic Ulcer Evaluation 1 → Ch 992 Myocardial Infarction Histology 2 → Ch 993 ST-Elevation Myocardial Infarction Pathogenesis 1 → Ch 994 Hypersensitivity Pneumonitis 2 → Ch 995 Hemolytic Uremic Syndrome 1 → Ch 996 West Lung Zones / Pulmonary Blood Flow 1 → Ch 997 Cystic Fibrosis Inheritance 1 → Ch 998 Chronic Pulmonary Aspergillosis 3 → Ch 999 Lupus Nephritis 1 → Ch 1000 Budd-Chiari Syndrome in Polycythemia Vera 2 → Ch 1001 Bronchial Asthma Spirometry 2 → Ch 1002 Amikacin Adverse Effects 1 → Ch 1003 Catecholamine Synthesis 1 → Ch 1004 Urinary Bladder Epithelium 1 → Ch 1005 COPD Oxygen Therapy 1 → Ch 1006 Ceruminous Glands 2 → Ch 1007 Lacunar Stroke / Internal Capsule 1 → Ch 1008 Syringomyelia 2 → Ch 1009 Herpes Zoster 1 → Ch 1010 Hyperglycemia-Related Hyponatremia 1 → Ch 1011 Philadelphia Chromosome / Chronic Myeloid Leukemia 3 → Ch 1012 Clear Cell Renal Cell Carcinoma / VHL 1 → Ch 1013 Neurogenic Pulmonary Edema 1 → Ch 1014 Cellular Hypertrophy and Hyperplasia 1 → Ch 1015 Intrapleural Pressure 1 → Ch 1016 Pulmonary Surfactant Function 2 → Ch 1017 Appendicular Artery 2 → Ch 1018 Cyanotic Congenital Heart Disease 1 → Ch 1019 Pulmonary Embolism Imaging 2 → Ch 1020 Li-Fraumeni Syndrome / TP53 1 → Ch 1021 Reticulocyte Maturation 2 → Ch 1022 DiGeorge Syndrome / 22q11 Deletion 1 → Ch 1023 Inferior MI with AV Block 2 → Ch 1024 Narcolepsy / Orexin Deficiency 2 → Ch 1025 STEMI Reperfusion / Primary PCI 1 → Ch 1026 Hypospadias Embryology 1 → Ch 1027 Normal Distribution / Standard Deviation 1 → Ch 1028 Acute Gout / Colchicine 1 → Ch 1029 Reactive Arthritis 1 → Ch 1030 Neurosyphilis / Tabes Dorsalis 1 → Ch 1031 Thrombotic Thrombocytopenic Purpura 1 → Ch 1032 Menkes Disease / ATP7A 1 → Ch 1033 Hepatic Encephalopathy 1 → Ch 1034 Stimulant Laxatives 2 → Ch 1035 Subclinical Hypothyroidism 1 → Ch 1036 Graves Disease / Radioactive Iodine 1 → Ch 1037 Psoriasis 1 → Ch 1038 Congenital Diaphragmatic Hernia 1 → Ch 1039 Cardiac Tamponade 1 → Ch 1040 Electron Transport Chain Complex II 1 → Ch 1041 Oculomotor Nerve Palsy 1 → Ch 1042 Iron Deficiency Anemia 1 → Ch 1043 Horner Syndrome 1 → Ch 1044 Insulin Receptor Signaling 1 → Ch 1045 Hemophilia A Inheritance 1 → Ch 1046 Digoxin Mechanism 1 → Ch 1047 Hemiazygos Vein Drainage 1 → Ch 1048 Acanthosis Nigricans / Insulin Resistance 1 → Ch 1049 Glucose Tolerance Testing 1 → Ch 1050 Obesity-Related Inflammation / TNF-α 1 → Ch 1051 Bitemporal Hemianopia / Optic Chiasm 1 → Ch 1052 Complement Consumption in SLE 1 → Ch 1053 Invasive Pulmonary Aspergillosis 1 → Ch 1054 Early Starvation Energy Source 1 → Ch 1055 Dorsal Column Pathway 1 → Ch 1056 Chronic Benzodiazepine Therapy and Anesthesia 1 → Ch 1057 Autoimmune Polyendocrine Syndrome 1 → Ch 1058 Lesch-Nyhan Syndrome / HGPRT 1 → Ch 1059 Alcoholic Hepatitis 1 → Ch 1060 Pseudocholinesterase Deficiency 1 → Ch 1061 Parkinson Disease / Dopamine Deficiency 1 → Ch 1062 Prefrontal cortex functions 1 → Ch 1063 Graft-versus-host disease 1 → Ch 1064 Septic shock 2 → Ch 1065 Post-ileal resection diarrhea 1 → Ch 1066 Gastric parietal cells 1 → Ch 1067 Compensation for hypoxic hypoxia 1 → Ch 1068 Clonorchis sinensis infection 1 → Ch 1069 Uterine involution 1 → Ch 1070 Renal agenesis 1 → Ch 1071 Irreversible cell injury 1 → Ch 1072 Maintenance dose calculation 2 → Ch 1073 Bleeding time and primary hemostasis 1 → Ch 1074 Eosinophilia with heart failure 1 → Ch 1075 Myeloproliferative neoplasms 1 → Ch 1076 GnRH secretion 1 → Ch 1077 Hypereosinophilic syndrome 1 → Ch 1078 Lingual nerve anatomy 1 → Ch 1079 Deep inguinal ring 1 → Ch 1080 Pendular knee jerk 1 → Ch 1081 Dissociated sensory loss 1 → Ch 1082 Lithium adverse effects 1 → Ch 1083 Parasympathetic control of heart rate 1 → Ch 1084 Hyperemesis gravidarum acid-base effects 1 → Ch 1085 Rods and dark adaptation 1 → Ch 1086 Cone phototransduction 1 → Ch 1087 Sjögren syndrome 1 → Ch 1088 Infantile cholestasis 1 → Ch 1089 TNM primary tumor staging 1 → Ch 1090 Dietary fiber effects 1 → Ch 1091 Ketamine and intracranial pressure 1 → Ch 1092 Ciliated columnar epithelium 1 → Ch 1093 Thyroid development 1 → Ch 1094 Digoxin cardiac action 1 → Ch 1095 GFAP in astrocytoma 1 → Ch 1096 Candida albicans germ-tube test 1 → Ch 1097 Esophageal squamous cell carcinoma 1 → Ch 1098 Regulation of gastric motility 1 → Ch 1099 Squamous cell carcinoma histology 1 → Ch 1100 Cerebral blood flow 1 → Ch 1101 Middle meningeal artery 1 → Ch 1102 Diphtheria complications 1 → Ch 1103 Posterior intercostal arteries 1 → Ch 1104 Secretory phase of endometrium 1 → Ch 1105 Tongue lymphatic drainage 1 → Ch 1106 Buttock lymphatic drainage 1 → Ch 1107 Jugular foramen structures 1 → Ch 1108 Facial nerve lesion 1 → Ch 1109 ADA deficiency SCID 1 → Ch 1110 Aspirin antiplatelet action 1 → Ch 1111 Disaccharide digestion and absorption 1 → Ch 1112 Immunodeficiency with transfusion reactions 1 → Ch 1113 Isotonic muscle contraction 1 → Ch 1114 AIDS-related skin malignancy 1 → Ch 1115 Cranial nerve control of eye movement 1 → Ch 1116 Identification of Staphylococcus aureus 1 → Ch 1117 Carnitine transport defect 1 → Ch 1118 Facial nerve lesion level 1 → Ch 1119 Physiological dead space in emphysema 1 → Ch 1120 Treatment of streptococcal pharyngitis 1 → Ch 1121 IgE-mediated allergy 1 → Ch 1122 First-degree burn 1 → Ch 1123 Referred shoulder pain from gallbladder 1 → Ch 1124 T12 abdominal structures 1 → Ch 1125 Pericardiocentesis approach 1 → Ch 1126 Hypokalemia ECG changes 1 → Ch 1127 Thiazide diuretics 1 → Ch 1128 ADH regulation 1 → Ch 1129 Coronary vasospasm 1 → Ch 1130 Thermal pain threshold 1 → Ch 1131 Acute graft rejection 1 → Ch 1132 Acute appendicitis histology 1 → Ch 1133 Femoral hernia anatomy 1 → Ch 1134 Chemotherapy-related hematuria 1 → Ch 1135 Aquaporin-2 and ADH 1 → Ch 1136 Staphylococcus aureus endocarditis 1 → Ch 1137 Tyrosine classification 1 → Ch 1138 Orbital spread of melanoma 1 → Ch 1139 Placental transfer 1 → Ch 1140 Opioid-MAO inhibitor interaction 1 → Ch 1141 Deep radial nerve lesion 1 → Ch 1142 Diphtheria toxin production 1 → Ch 1143 Lidocaine indications 1 → Ch 1144 Neuroblastoma chemotherapy 1 → Ch 1145 Autosomal dominant disorders 1 → Ch 1146 Weber syndrome 1 → Ch 1147 Warfarin mechanism 1 → Ch 1148 Chronic liver disease etiology 1 → Ch 1149 Healthcare-associated Staphylococcus aureus infection 1 → Ch 1150 Malignant mesothelioma 1 → Ch 1151 Symptomatic treatment of hyperthyroidism 1 → Ch 1152 Digoxin drug class 1 → Ch 1153 Postoperative deep vein thrombosis 1 → Ch 1154 Secretory endometrium 1 → Ch 1155 Duodenal arterial supply 1 → Ch 1156 Dorsalis pedis and first dorsal metatarsal artery 1 → Ch 1157 Lung volumes in pregnancy 1 → Ch 1158 Proto-oncogenes 1 → Ch 1159 Propranolol in hyperthyroidism 1 → Ch 1160 Upper trunk brachial plexus injury 1 → Ch 1161 Supraspinatus function 1 → Ch 1162 Second dorsal extensor compartment 1 → Ch 1163 Tuberculous granulomatous inflammation 1 → Ch 1164 Respiratory alkalosis 1 → Ch 1165 Respiratory compensation in DKA 1 → Ch 1166 G6PD deficiency and oxidant hemolysis 1 → Ch 1167 Carbon unit metabolism 1 → Ch 1168 Platelet inflammatory mediators 1 → Ch 1169 Atrial fibrillation and AV nodal conduction 1 → Ch 1170 Fluoroquinolone joint toxicity 1 → Ch 1171 PAH clearance 1 → Ch 1172 Staphylococcus aureus tricuspid endocarditis 1 → Ch 1173 Visual cortex and lateral geniculate nucleus 1 → Ch 1174 Optic tract lesion 1 → Ch 1175 Hypercalcemia 1 → Ch 1176 Ventilation during exercise and altitude 1 → Ch 1177 Antihypertensive therapy in LVH 1 → Ch 1178 Aortic hiatus at T12 1 → Ch 1179 Hemolytic anemia 1 → Ch 1180 Glanzmann thrombasthenia 1 → Ch 1181 Allergic contact dermatitis 1 → Ch 1182 Rh hemolytic disease 1 → Ch 1183 Adult bacterial meningitis 1 → Ch 1184 Warfarin-cimetidine interaction 1 → Ch 1185 Pancreatic lipase deficiency 1 → Ch 1186 Autoimmune pancreatitis 1 → Ch 1187 Sella turcica 1 → Ch 1188 SIADH 1 → Ch 1189 Renal response to hypovolemic shock 1 → Ch 1190 Pioglitazone mechanism 1 → Ch 1191 Epididymal function 1 → Ch 1192 Fever with hemorrhagic manifestations in pregnancy 1 → Ch 1193 Monocular visual field defect 1 → Ch 1194 Clinical measurement of GFR 1 → Ch 1195 Clinical uses of anticholinergics 1 → Ch 1196 Glucocorticoids in shock 1 → Ch 1197 Efferent arteriolar constriction 1 → Ch 1198 Molecular mimicry in rheumatic fever 1 → Ch 1199 Metronidazole adverse effects 1 → Ch 1200 Layers of thoracic wall 1 → Ch 1201 Treatment of Enterococcus faecalis 1 → Ch 1202 Initial management of hemorrhagic shock 1 → Ch 1203 Diaphragm contribution to inspiration 1 → Ch 1204 Thiamine and pyruvate dehydrogenase 1 → Ch 1205 Focal segmental glomerulosclerosis 1 → Ch 1206 Chemotherapy-associated anemia 1 → Ch 1207 Naloxone duration of action 1 → Ch 1208 Staphylococcal food poisoning 1 → Ch 1209 Group A streptococcal pharyngitis 1 → Ch 1210 Inflammatory exudate 1 → Ch 1211 Langhans giant cells 1 → Ch 1212 Reactive thrombocytosis 1 → Ch 1213 Long-term glucocorticoid adverse effects 1 → Ch 1214 Anti-inflammatory effects of glucocorticoids 1 → Ch 1215 Rheumatic heart disease valve involvement 1 → Ch 1216 Marfan syndrome and aortic degeneration 1 →

No topics match.